Ocular Therapeutix (OCUL) FCF Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -47,003.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47,003.00 |
| Dec 31, 2025 | -20,558.00 |
| Sep 30, 2025 | -27,797.00 |
| Jun 30, 2025 | -33,125.00 |
| Mar 31, 2025 | -29,249.00 |
| Dec 31, 2024 | -10,284.00 |
| Sep 30, 2024 | -11,965.00 |
| Jun 30, 2024 | 1,577.00 |
| Mar 31, 2024 | 548.00 |
| Dec 31, 2023 | -2,853.00 |
| Sep 30, 2023 | 17,429.00 |
| Jun 30, 2023 | 78,769.00 |
| Mar 31, 2023 | 57,802.00 |
| Dec 31, 2022 | 70,833.00 |
| Sep 30, 2022 | 215,458.00 |
| Jun 30, 2022 | 302,282.00 |
| Mar 31, 2022 | 383,288.00 |
| Dec 31, 2021 | 233,069.00 |
| Sep 30, 2021 | 233,721.00 |
| Jun 30, 2021 | 167,161.00 |
| Mar 31, 2021 | 354,402.00 |
| Dec 31, 2020 | 209,277.00 |
| Sep 30, 2020 | 234,002.00 |
| Jun 30, 2020 | 150,244.00 |
| Mar 31, 2020 | 268,486.00 |
| Dec 31, 2019 | 77,088.00 |
| Sep 30, 2019 | -50,935.00 |
| Jun 30, 2019 | -87,064.00 |
| Mar 31, 2019 | -172,481.00 |
| Dec 31, 2018 | -14,700.00 |
| Sep 30, 2018 | 2.14 Mn |
| Jun 30, 2018 | 20,584.00 |
| Mar 31, 2018 | -74,151.00 |
| Dec 31, 2017 | -103,842.00 |
| Sep 30, 2017 | 182,850.00 |
| Jun 30, 2017 | 198,163.00 |
| Mar 31, 2017 | 1.26 Mn |